Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 (COVID-19) S1 RBD Single Domain | RBD-2B9 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) S1 RBD Single Domain | T3P1-C8 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) S1 RBD Single Domain | T4P5-H12 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) S1 RBD Single Domain | T5P4-A12 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) S1 RBD Single Domain | T5P7-G10 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S1 | polyclonal | Rabbit | n/a | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-COV-2 Spike protein | polyclonal | Chicken | n/a | affinity purified | 100 µg | n/a |
AFFINITY IMMUNO INC. |
More Info |
CoV2 Nucleocapsid | polyclonal | Rabbit | n/a | unconjugated | 1 mg, 0.5 mg, 100 ug | n/a |
BIORBYT LTD. |
More Info |
Nucleocapsid CoV-2 | CBP17443 | Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |